Home > Press > IBN Engineers World’s First Tri-Continuous Mesoporous Silica Complex Structure Useful for Catalysis, Separation and Drug Delivery
Abstract:
Technology useful for catalysis, separation and drug delivery
Singapore's Institute of Bioengineering and Nanotechnology (IBN) has developed the first tri-continuous mesoporous material using a unique surfactant template. This completely new porous structure previously been predicted only mathematically.
In the current Nature Chemistry, the IBN scientists report that this novel material, named IBN-9 after the research institute, is the first hexagonal nanoscale construct with 3 unconnected interwoven channels. It is by far the most complex mesoporous nanostructure to have been synthesized in real-life and represents a new class of mesoporous materials, which consist of pores of 2-50 nanometers in size.
Mesoporous silica has well-defined nanochannel structures that are formed over templates via self-assembly processes. Mesoporous silica materials have huge surface areas, making them ideal for use as catalysts to facilitate chemical reactions. Their uniform nanometersized pores allow them to separate molecules by size difference. Their pores may also be used to trap drug molecules for controlled drug release. Therefore, the ability to tailor the pore structure of mesoporous material is of fundamental importance for various chemical and biological applications.
"IBN-9 demonstrates that it is possible to create three interwoven but independent pore channel systems along with a unique nano-fiber morphology," said Jackie Y. Ying, Ph.D., who led this research.
"Such a mesostructure makes distinct diffusion rates in different directions possible. This property would be very attractive for gas separation and drug delivery systems" added Dr. Ying, Executive Director of IBN, which is part of Singapore's A*STAR (Agency for Science, Technology and Research).
There has been tremendous interest about tailoring mesoporous materials with unique pore structures and pore sizes. The most complex of these were the bi-continuous structures, which contain two unconnected interwoven channels. These materials are synthesized via self-assembly of silica around surfactant templates.
IBN researchers successfully synthesized the first tri-continuous mesoporous structure by using a specially designed surfactant template, N,N-dimethyl-L-phenylalanine. This surfactant has a unique tunable head-group as well as a long hydrocarbon tail that has variable levels of hydrophobic (water-repellent) qualities. By systematically changing the synthesis conditions using this surfactant, IBN researchers are able to achieve structures with increasing mean curvatures from the bi-continuous cubic IBN-6 to the tri-continuous 3D hexagonal IBN-9, and finally to the 2D hexagonal IBN-10. The structural complexity of IBN-9 and its sister materials opens the possibility of creating even more complex multi-continuous mesostructures.
Original publications: Y. Han et al.; "A Tri-Continuous Mesoporous Material, IBN-9, with a Silica Pore Wall Following a Hexagonal Minimal Surface," Nature Chemistry 2009
S. T. Hyde and G. E. Schröder; "Novel Surfactant Mesostructural Topologies: Between Lamellae and Columnar (Hexagonal) Forms"; Current Opinion in Colloid and Interface Science, 8 (2003) 5-14
####
About Institute of Bioengineering and Nanotechnology
Committed to the pursuit of excellence in biomedical sciences and guided by its mission of “Charting New Frontiers in Science, Engineering and Medicine” of Singapore's life science industry, IBN will:
LEAD - Provide international leadership in bioengineering and nanotechnology
INNOVATE - Conduct innovative research and create intellectual properties
FACILITATE - Play and active role in technology transfer
TRAIN - Foster an exciting multidisciplinary research environment for the training of students and young researchers
For more information, please click here
Contacts:
Tel: +65 6824 7000
31 Biopolis Way
The Nanos, #04-01
Singapore 138669
Fax: +65 6478 9080
Copyright © Chemie.DE
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Chemistry
Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Self Assembly
Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024
Liquid crystal templated chiral nanomaterials October 14th, 2022
Nanoclusters self-organize into centimeter-scale hierarchical assemblies April 22nd, 2022
Atom by atom: building precise smaller nanoparticles with templates March 4th, 2022
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||